Global Beta-Thalassemia Market Size, Share, and COVID-19 Impact Analysis By Treatment (Iron Chelating Drugs, Erythyroid maturation agents, Stem Cell therapy, and Others), By Disease Indication ( Beta Thalassemia Minor, Beta Thalassemia Intermediate and Beta Thalassemia Major), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

Industry: Healthcare
RELEASE DATE Oct 2022
REPORT ID SI1234
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Treatment
      2. Market Attractiveness Analysis By Disease Indication
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1.   Rise in prevelance
    3. Restraints
      1.   High cost
    4. Opportunities
      1.  Rise in research and development
    5. Challenge

5.5.1.     lack of awareness

  1. Global Beta-Thalassemia Market Analysis and Projection, By Treatment
    1. Segment Overview
    2. Iron Chelating Drugs
    3. Erythyroid maturation agents
    4. Stem Cell therapy
    5. Others
  2. Global Beta-Thalassemia Market Analysis and Projection, By Disease Indication
    1.  Segment Overview
    2.  Beta Thalassemia Minor
    3.  Beta Thalassemia Intermediate
    4.  Beta Thalassemia Major
  3. Global Beta-Thalassemia Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Beta-Thalassemia Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Beta-Thalassemia Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1.  Celgene Corp.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
    2. SWOT Analysis
  6.  BlueBird Bio
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  7.  Agios Pharmaceuticals
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  8.  Ionis Pharmaceuticals
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  9.  Vifor Pharma
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  10.    Orchard Therapeutics
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  11.  Sangamo Therapeutics
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  2. Global Iron Chelating Drugs, Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  3. Global Erythyroid maturation agents, Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  4. Global Stem Cell therapy, Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  5. Global Others, Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  6. Global Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  7. Global Beta Thalassemia Minor, Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  8. Global Beta Thalassemia Intermediate, Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  9. Global Beta Thalassemia Major, Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  10. Global Beta-Thalassemia Market, By Region, 2022-2030(USD million)
  11. North America Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  12. North America Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  13. U.S.  Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  14. U.S.  Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  15. Canada Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  16. Canada Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  17. Mexico Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  18. Mexico Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  19. Europe Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  20. Europe Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  21. Germany Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  22. Germany Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  23. France Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  24. France Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  25. U.K. Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  26. U.K.  Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  27. Italy Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  28. Italy Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  29. Spain Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  30. Spain Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  31. Asia Pacific Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  32. Asia Pacific Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  33. Japan Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  34. Japan Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  35. China Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  36. China Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  37. India Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  38. India Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  39. South America Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  40. South America Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  41. Brazil Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  42. Brazil Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  43. The Middle East and Africa Beta-Thalassemia Market, By Treatment, 2022-2030(USD   million)
  44. The Middle East and Africa Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million)
  45. UAE Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  46. UAE Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD million) 
  47. South Africa Beta-Thalassemia Market, By Treatment, 2022-2030(USD million)
  48. South Africa Beta-Thalassemia Market, By Disease Indication, 2022-2030(USD Million)

List of Figures 

  1. Global Beta-Thalassemia Market Segmentation
  2. Beta-Thalassemia Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Beta-Thalassemia Market
  9. Top Winning Strategies, 2022-2030
  10. Top Winning Strategies, By Development, 2022-2030(%)
  11. Top Winning Strategies, By Company, 2022-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers: Beta-Thalassemia Market
  20.  Beta-Thalassemia Market Segmentation, By Treatment
  21.  Beta-Thalassemia Market For Iron Chelating Drugs, By Region, 2022-2030 ($ million)
  22.  Beta-Thalassemia Market For Erythyroid maturation agents, By Region, 2022-2030 ($ million)
  23.  Beta-Thalassemia Market For Stem Cell therapy, By Region, 2022-2030 ($ million)
  24. Beta-Thalassemia Market For Others, By Region, 2022-2030 ($ million)
  25.  Beta-Thalassemia Market Segmentation, By Disease Indication
  26.  Beta-Thalassemia Market For Beta Thalassemia Minor, By Region, 2022-2030 ($ million)
  27.  Beta-Thalassemia Market For Beta Thalassemia Intermediate, By Region, 2022-2030 ($ million)
  28. Beta-Thalassemia Market For Beta Thalassemia Major, By Region, 2022-2030 ($ million)
  29. Procter & Gamble: Net Sales, 2022-2030 ($ million)
  30. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  31. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  32. PHYTOMER: Net Sales, 2022-2030 ($ million)
  33. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  34. PHYTOMER: Revenue Share, By Region, 2022 (%)
  35. Deka Corporation: Net Sales, 2022-2030 ($ million)
  36. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  37. Deka Corporation: Revenue Share, By Region, 2022 (%)
  38. Johnson & Johnson: Net Sales, 2022-2030 ($ million)
  39. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  40. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  41. Unilever Plc.: Net Sales, 2022-2030 ($ million)
  42. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  43. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  44. Kao Corporation: Net Sales, 2022-2030 ($ million)
  45. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  46. Kao Corporation: Revenue Share, By Region, 2022 (%)
  47. ZO Skin Health, Inc.: Net Sales, 2022-2030 ($ million)
  48. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  49. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  50. L’Oreal Paris: Net Sales, 2022-2030 ($ million)
  51. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  52. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  53. Shiseido Company Limited: Net Sales, 2022-2030 ($ million)
  54. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  55. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  56. Estee Lauder Companies, Inc.: Net Sales, 2022-2030 ($ million)
  57. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  58. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:106
Pages:240
Countries covered:17
Companies covered::7
Forecast CAGR:8%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies